The Paradise uRDN system is currently commercially available for patients in the US having received FDA approval in November 2023. It is indicated to reduce blood pressure as an adjunctive treatment ...
Verywell Health on MSN8d
What Causes Postpartum Hypertension (and How to Treat It)?Hypertension in pregnancy increases the likelihood of postpartum hypertension. Know the risk factors to start managing ...
The consequences of primary aldosteronism mainly result from the activation of the mineralocorticoid receptor. Two of these ...
PAH is a rare condition in children, but is often fatal if left untreated, and protocols for pediatric patients have not been ...
While high blood pressure can contribute to renovascular disease, having renal (kidney) problems can also increase blood ...
As prevalence of CVDs continues to increase, the AHA and AMA have developed the Target BP initiative to improve blood ...
Erri, S. and Oroszi, T. (2025) Isolated Systolic Hypertension in Geriatrics. International Journal of Clinical Medicine, 16, ...
Time-restricted eating, particularly among people with underlying metabolic disorders, may confer benefits beyond weight loss ...
Targeted Medical Pharma, Inc. (OTCMKTS:TRGM – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.00 and ...
Gestational hypertension, or high blood pressure developed during the latter half of pregnancy, is becoming a more common complication as the average childbearing age for women has increased. Trends ...
AliveGen USA Inc. (AliveGen), a clinical stage biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ALG-801 for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback